Schedule your consultation for our weight loss program by calling 757-481-4036!
The three-way comparison between semaglutide, tirzepatide, and retatrutide provides the broadest perspective on the current GLP-1 landscape
BPC-157 is a short chain of amino acids derived from protective gastric proteins
Clinical trial data on Retatrutides benefits is striking: Weight loss up to 24% of total body weight within 48 weeks outpacing both semaglutide and tirzepatide in head-to-head comparisons 3050% reduction in appetite , making dietary adherence significantly easier Visceral fat reduction of up to 40%, targeting the most metabolically harmful fat stored around organs Improved glycemic control and reduced insulin resistance, with benefits for those at risk of or managing type 2 diabetes Liver health improvement emerging data suggests positive effects on non-alcoholic fatty liver disease (NAFLD) Elevated resting energy expenditure , meaning your body burns more calories at rest For residents of Dubai pursuing sustainable, medically supervised weight management, these outcomes represent a meaningful leap forward
It is fresh for use
Systemic mechanism A synthetic fragment of Thymosin Beta-4, studied for regulating actin, the protein that drives cell migration and blood vessel formation